Sign in

CIK 0001157601 · Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(267) 824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
  1. 424B5 Offering Prospectus
  2. 4 Open-market buy Director bought 11,059 shares at $3.95 ($43,727)
  3. 8-K Event Material agreement
  4. 4 Open-market buy Director bought 8,844 shares at $3.96 ($35,024)
  5. 4 Open-market buy Director bought 25,016 shares at $3.94 ($98,473)
  6. 4 Open-market buy Director bought 8,000 shares at an average $3.98 ($31,832)
  7. 4 Open-market buy Director bought 54,640 shares at an average $3.79 ($207,219)
  8. 8-K Event Agreement ended
  9. 10-Q Report Quarterly Report
  10. 4 Open-market buy Director bought 153,234 shares at an average $3.79 ($580,158)
  11. 4 Open-market buy Director bought 96,457 shares at an average $3.84 ($370,503)
  12. 4 Open-market buy SVP, Chief Medical Officer bought 2,500 shares at an average $4.01 ($10,022)
  13. 4 Open-market buy Director bought 100 shares at $3.85 ($385)
  14. 4 Open-market buy Director bought 15,764 shares at an average $3.75 ($59,189)
  15. 4 Open-market buy Director bought 3,303 shares at $3.79 ($12,510)
  16. EFFECT Other Notice of Effectiveness
  17. 8-K Event Material agreement
  18. 424B2 Offering Prospectus
  19. CT ORDER Other Confidential Order
  20. 4 Open-market buy Director bought 128,142 shares at an average $3.73 ($477,576)

Page 48 of 62 · 1,224 filings